Delivery Order SPE2DB20D1100-SPE2DB24FB1Q6

Award Date 4/8/24
Potential Completion Date 4/29/24
Potential Value $7.1K
Ultimate Awardee
Cencora, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a leading pharmaceutical distributor, for the supply of the drug Erleada (60 mg tablets) valued at $7,106.87. The award has an ultimate completion date of April 30, 2024. Amerisourcebergen Drug Corp, through its Corporate Office division, is the prime contractor on this delivery order, which does not have a set-aside designation. The company also holds a...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is a $7,558.78 firm fixed-price delivery order for 4566584342 ERLEADA 60 MG TABLET UU 120S, with a completion date of December 23, 2024. Amerisourcebergen also holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) Troop Support Medical. The $7,352.49 firm fixed-price delivery order is for the supply of ERLEADA 240 MG TABLET UU 30S, a medical product, with a completion date of March 17, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
The Defense Logistics Agency (DLA) Troop Support Medical awarded Amerisourcebergen Drug Corp's Corporate Office Division a firm fixed-price delivery order contract worth $7,306.27. The contract, which has an ultimate completion date of October 10, 2024, is for the supply of 4565868618 ERLEADA 60 MG TABLET UU 120S. This contract award is not associated with any set-aside designation. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that holds several Indefinite Delivery Contracts...
The Defense Logistics Agency (DLA) has awarded Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a firm fixed price delivery order contract valued at $34,838.56 to provide ERLEADA 60 MG TABLET UU 120S. This contract has a completion date of February 27, 2024. Amerisourcebergen Drug Corp, a for-profit organization, serves as the prime contractor for this delivery order, which is not designated as a set-aside. The company holds an Indefinite Delivery Contract (IDC) with...
This is a delivery order awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $7,106.87, is for the provision of ERLEADA 60 MG TABLET UU 120S, a pharmaceutical product. The contract is a firm fixed price delivery order with a period of performance through May 26, 2023. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at...
This is a firm fixed-price delivery order award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) to supply ERLEADA 240 MG tablets. The $7,352.49 award has a February 2025 completion date and is not designated as a set-aside contract. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a comprehensive range of pharmaceutical products and medical supplies,...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the provision of 4,564,986,477 units of the pharmaceutical product ERLEADA 240 MG TABLET in packages of 30. The contract has a ceiling value of $7,106.87 and is a Delivery Order under a larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical. This single-award IDC, valued up to $999,999,999.00, serves as the primary vehicle for Amerisourcebergen to deliver...
This is a delivery order under an Indefinite Delivery Contract (IDC) awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $14,612.56, is for the delivery of 120 tablets of the drug ERLEADA 60 MG. The contract has a firm fixed price pricing type and a completion date of November 14, 2024. This delivery order is part of a larger $999,999,999 IDC that...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office division, a major pharmaceutical distributor. The $21,918.81 firm fixed-price contract is for the supply of 4,565,953,510 tablets of the prescription drug Erleada 60 mg. The contract has an ultimate completion date of October 18, 2024. This award is a part of Amerisourcebergen's existing Indefinite Delivery Contract (IDC) with the DLA Troop...
  • SPE2DB20D1100
    Indefinite Delivery Contract
  • SPE2DB20D1100-SPE2DB24FB1Q6
    Delivery Order

This contract award to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, provides pharmaceutical products and medical supplies to the Defense Logistics Agency (DLA) Troop Support Medical. The $7,106.87 firm fixed price delivery order is for the medication Erleada 60 mg tablet and has an ultimate completion date of April 29, 2024.

Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with DLA valued up to $999,999,999.00 through December 31, 2025. This IDC serves as the primary vehicle for Amerisourcebergen to deliver pharmaceuticals and medical materials to support Department of Defense military treatment programs and facilities worldwide. No set-aside designation was used for this specific delivery order or the overarching IDC.

Generated 7/8/24, 9:30 AM